BRING-UP 3 Heart Failure
NCT06279988
Summary
The aim of this observational study is to assess the level of adherence to guideline recommendations regarding the management of patients with Heart Failure with Reduced Ejection Fraction (HFrEF); - the safety profile of the implementation of recommended treatments; - to monitor treatment patterns of patients with acute hert failure (HF); - to monitor treatment patterns of all patients with chronic HF irrespective of the level of ejection fraction (EF).
Eligibility
Inclusion Criteria: 1. Age ≥18 years old. 2. Males and females at birth. 3. Any ejection fraction level (level of ejection fraction measured in the 6 months preceding enrollment). 4. Ambulatory chronic HF or Hospitalized de-novo or worsening HF. 5. Signed informed consent Diagnosis will be made by the local attending physician following the ESC guidelines recommendations. Exclusion Criteria: 1. Active neoplasia or very severe disease compromising short-medium term life expectancy. 2. Participation in interventional studies. 3. Patients already enrolled into the study from another participating center or in the previous enrolling phase.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06279988